SCHEMBL17848871

SCHEMBL17848871

CCCCOC(=O)N1CC(F)CC1c1cc(F)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.42
ECE1 P42892 1/20 0.38
GBA2 Q9HCG7 1/20 0.37
RIPK1 Q13546 2/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.35
DPP4 P27487 1/20 0.35
FAP Q12884 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
MCHR1 Q99705 1/20 0.34
HCRTR2 O43614 1/20 0.34
HTR2A P28223 1/20 0.34
NTRK1 P04629 2/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
JAK2 O60674 1/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30063990 0.88 ECE1 (0.42) SCN9AECE1GBA2PTGDR2DPP4
SCHEMBL932669 0.81 RIPK1 (0.46) RIPK1HCRTR2NTRK1JAK2
SCHEMBL17821025 0.80 NTRK1 (0.44) SCN9ARIPK1NTRK1
SCHEMBL17820744 0.80 NTRK1 (0.44) SCN9ARIPK1NTRK1
SCHEMBL17820748 0.80 NTRK1 (0.44) SCN9ARIPK1NTRK1
SCHEMBL23083856 0.80 NTRK1 (0.44) SCN9ARIPK1NTRK1
SCHEMBL21313058 0.77 SCN9A (0.44) SCN9ARIPK1DPP4FAPDPP8
SCHEMBL21313092 0.77 SCN9A (0.44) SCN9ARIPK1DPP4FAPDPP8
SCHEMBL29891866 0.76 HTR2A (0.39) HTR2A
SCHEMBL932557 0.75 NTRK1 (0.44) RIPK1PTGDR2LMNARECQLHCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233863-A1 FUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS CMG Pharmaceutical Co., Ltd. (KR) 2017-10-25 EP disclosed
WO-2016097869-A1 FUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS CMG PHARMACEUTICAL CO., LTD. (KR) 2016-06-23 WO disclosed